OBI Pharma Long-term Investment Intensity
OBI Pharma long-term investment intensity. OBI Pharma (4174) has a Long-term Investment Intensity of 0.1% as of September 2019. Long-term investments of NT$7.14 Million represent 0.1% of total assets of NT$5.97 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read 4174 total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of OBI Pharma (2015–2018)
Long-term investment intensity of OBI Pharma from 2015 to 2018. This chart shows how OBI Pharma's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 0.1%, reflecting long-term investments of NT$7.14 Million against total assets of NT$5.97 Billion TWD.
OBI Pharma Long-term Investment Intensity by Year (2015–2018)
OBI Pharma long-term investment intensity by year from 2015 to 2018. The table below presents the year-by-year Long-term Investment Intensity for OBI Pharma from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 4174 asset base.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.2% | NT$7.45 Million | NT$4.71 Billion | ▼ 0.0 pp |
| 2017 | 0.2% | NT$10.16 Million | NT$5.19 Billion | ▼ -33.6 pp |
| 2016 | 33.8% | NT$2.14 Billion | NT$6.33 Billion | ▼ -31.6 pp |
| 2015 | 65.4% | NT$4.78 Billion | NT$7.31 Billion | — |